USPlabs OxyELITE Pro Ultra-Intense Thermo Advanced Formula DIETARY SUPPLEMENT Manufactured for USPlabs, LLC (Dallas, TX 75220), sold in the following sizes: 3 count; 90 count; and 180 count.
Recalling firm: USPlabs, LLC
USPlabs, LLC received a 423(a), Notification of Opportunity to Initiate a Voluntary Recall, letter from FDA and is recalling products containing Aegeline and associated with serious adverse health events, namely serious liver damage or acute liver failure.
Check your package
Compare the exact product and package details with the label you have.
FDA code information
3 count capsules, UPC #094922447883; 3 count capsules UPC #094922447876; 90 count capsules, UPC #094922395627; 180 count capsules UPC #094922447869
Match the product, package size, and code together. A missing match does not guarantee safety.
Full FDA record and distribution details
Original product description
USPlabs OxyELITE Pro Ultra-Intense Thermo Advanced Formula DIETARY SUPPLEMENT Manufactured for USPlabs, LLC (Dallas, TX 75220), sold in the following sizes: 3 count; 90 count; and 180 count.
Extracted codes and context
| Type | Code / value | Context |
|---|---|---|
| UPC | 094922395627 | UPC #094922447883; 3 count capsules UPC #094922447876; 90 count capsules, UPC #094922395627; 180 count capsules UPC #094922447869 |
| UPC | 094922447869 | PC #094922447876; 90 count capsules, UPC #094922395627; 180 count capsules UPC #094922447869 |
| UPC | 094922447876 | 3 count capsules, UPC #094922447883; 3 count capsules UPC #094922447876; 90 count capsules, UPC #094922395627; 180 count capsules UPC #094922447869 |
| UPC | 094922447883 | 3 count capsules, UPC #094922447883; 3 count capsules UPC #094922447876; 90 count capsules, UPC #094922395627; 180 count capsules UPC #094922447869 |
Recall details
- Recall number
- F-1371-2014
- Event ID
- 66813
- FDA status
- Terminated
- Initiated
- Nov 9, 2013
- Reported
- Jan 22, 2014
- Classified
- Jan 15, 2014
- Terminated
- Oct 13, 2015
- Quantity
- 1,065,783 units
- Location
- Dallas, TX, United States
- Initiation type
- Voluntary: Firm initiated
- Notification
- Press Release
Where it was distributed
Worldwide distribution including the following Worldwide distribution including the following international countries: Ecuador, Russia, UAE, South America, Dominican Republic, Kuwait, Philippines, Indonesia, Egypt, Panama, China, and Argentina.
Data updated September 16, 2026. View official FDA data ↗
Follow official FDA and manufacturer guidance.